Biograil Overview
- Founded
- 2019
- Status
- Private
- Latest Deal Type
- Seed
- Latest Deal Amount
- $3.62M
- Investors
- 6
Biograil General Information
Description
Developer of a medical device designed to replace the standard injection system of medicines. The company's device is based upon an injection molding technique and uses the body's own peristaltic forces to facilitate the delivery of the biologic efficiently into the gastrointestinal wall, enabling patients to receive medicines in a painless way.
Contact Information
Website
www.biograil.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
- Baldersbuen 2
- 2640 Hedehusene
- Denmark
+45 21 00 00 00
Biograil Timeline
Biograil Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Seed Round | 17-Feb-2022 | $3.62M | 00.000 | Completed | Generating Revenue | |
| 3. Early Stage VC (Series A) | 20-Jan-2020 | Cancelled | Generating Revenue | |||
| 2. Seed Round | 20-Jan-2020 | $3.34M | $3.34M | Completed | Generating Revenue | |
| 1. Angel (individual) | Completed | Pre-Clinical Trials |
Biograil Patents
Biograil Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3083068-A1 | Oral delivery of active drug substances | Pending | 18-Dec-2017 | 0000000000 | |
| AU-2018387769-A1 | Oral delivery of active drug substances | Pending | 18-Dec-2017 | 0000000000 | |
| EP-3727555-A1 | Oral delivery of active drug substances | Pending | 18-Dec-2017 | 0000000000 | |
| JP-2021506521-A | Oral delivery of active drug substance | Pending | 18-Dec-2017 | 0000000000 | |
| US-20210290918-A1 | Oral delivery of active drug substances | Pending | 18-Dec-2017 | A61M31/002 |
Biograil Executive Team (4)
Biograil Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Anke Caßing | Self | Board Member | 000 0000 |
| Christian Schierholz | Sanner Ventures | Board Observer | 000 0000 |
Biograil Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Evonik Venture Capital | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| High-Tech Gründerfonds | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Megatrend Invest | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Sanner Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Verve Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |